Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-Metastatic Prostate Cancer × Gefitinib × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 8 Urinary Bladder Neoplasms 4 Carcinoma, Renal Cell 4 Kidney Neoplasms 3 Urethral Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non-Metastatic Prostate Cancer 1 Locally Advanced Prostate Cancer 1 Gliosarcoma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Brain Neoplasms 1 Adenocarcinoma 1

Interventions

Radiotherapy 1 Gefitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00239291 2009-04-23

Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer

AstraZeneca

Phase 1/2 Completed

Non-Metastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡